Strides Shasun gets US FDA nod for anti-allergy capsules

PTI New Delhi | Updated on January 11, 2018 Published on July 24, 2017


Strides Shasun has received approval from the US Food and Drug Administration for cetirizine hydrochloride capsules, used to relieve allergy symptoms.

Strides Shasun said in a BSE filing: “It has received approval from the US FDA for cetirizine hydrochloride capsules, 10mg (liquid filled capsules OTC).“

The company said the product will be manufactured at its facility in Bengaluru and is ready for launch.

Quoting IRI data, Strides Shasun said the US market for cetirizine hydrochloride capsules is approximately $60 million, with only one other generic player.

The company shares were trading 0.16 per cent higher at Rs 1,081.20 on the BSE.

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on July 24, 2017
This article is closed for comments.
Please Email the Editor